KDA develops innovative solutions for global markets that drive health system transformation. To contact us, write to

KDA Group Announces Debt Restructuring With Persistence Capital Partners

8 May 2023

KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the restructuring, as of May 4, 2023, of its total debt owed to Persistence Capital Partners II, L.P. and Persistence Capital Partners II (International), L.P., (collectively “PCP”).

Learn more


15 March 2023

Thetford Mines, Quebec – March 15, 2023 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that it has engaged Cavendish Investment Corp. (“Cavendish”) to market the technology products of its wholly-owned subsidiary, Groupe Technologique KDA Inc., throughout the Asian market, including Hong Kong.

Learn more

KDA Group acquires Covapharm

21 December 2022

Thetford Mines, Quebec – December 21, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that it has acquired Covapharm Inc. (“Covapharm”) pursuant to a share purchase agreement (the “Share Purchase Agreement”) dated December 16, 2022, for a consideration of $200,000.00 payable in monthly instalments of $10,000.00 over a period of twenty (20) months from the closing date and a maximum of 1,825,000 Class A shares in the capital stock of the Corporation (the “KDA Shares”).

Learn more

KDA GROUP ANNOUNCES THE APPOINTMENT OF Luc Olivier as chief financial officer,18 OCTOBER 2022

18 October 2022

Thetford Mines, Quebec – October 18, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the appointment of Mr. Luc Olivier as Chief Financial Officer of the Corporation effective yesterday, October 17, 2022.

Learn more

kda group grants stock options

6 May 2022

Thetford Mines, Quebec – May 6, 2022 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that, pursuant to its stock option plan, it has granted incentive stock options to directors, officers, employees and consultants of the Corporation to purchase up to an aggregate of 5,025,000 Class A shares (the “Common shares”).

Learn more
1 2